Distress, anxiety, and depression in cancer patients undergoing chemotherapy

Pandey, Manoj; Sarita, Gangadharan Premalatha; Devi, Nandkumar; Thomas, Boben; Hussain, B.M.; Ravindran, Krishnan

doi:10.1186/1477-7819-4-68

Cited by 121 publications

(101 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In the studies of Gozum and Akçay, 53.2% of Turkish cancer patients receiving chemotherapy were reported to be depressive [13]. Pandey et al found depression to be present in 16.2% of cancer patients undergoing chemotherapy [14]. Tsunoda et al reported that 36.7% of colorectal cancer patients were depressive [15].…”

Section: Discussionmentioning

confidence: 97%

Quality of life, anxiety, and depression in Turkish colorectal cancer patients

Alacacıoğlu

Binicier

Güngör

et al. 2009

Support Care Cancer

View full text Add to dashboard Cite

One hundred ten patients with colorectal cancer undergoing chemotherapy who presented to Dokuz Eylul University Faculty of Medicine, Department of Oncology between January 2004 and April 2007 were included in this study. The series of forms including the questions regarding the demographic characteristics of the patient, Turkish version of the Beck Depression Inventory (BDI), the Turkish version of the STAI, and European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30 (EORTC-QLQ-C30; version 3) were completed during face-to-face interviews by trained interviewers to determine the psychological status and quality of life of the patients. The mean Beck depression scores were 11.2 +/- 9.0 (range 0-44) and the mean STAI scores were 41.9 +/- 8.8 (range 22-71). Of the patients (Beck depression scores >or=17 points), 23.6% were determined as depressive. The EORTC-QLQ-C30 function scales and global quality of life scores of the depressive patients (BDI >or= 17) were significantly lower than that of the nondepressive patients (BDI < 17). EORTC-QLQ-C30 symptom scale scores (excluding of the diarrhea) of the depressive patients were significantly higher than that of the nondepressive patients. The patients with low STAI scores (STAI < 45) had significantly higher EORTC-QLQ-C30 function scales and global quality of life scores than the patients with high STAI scores (STAI >or= 45). EORTC-QLQ-C30 symptom scale scores of the patients with high STAI scores were significantly higher than that of the patients with low STAI scores. In the present study, we detected that anxiety and depression were strongly associated with poor quality of life in Turkish colorectal cancer patients.

show abstract

Section: Discussionmentioning

confidence: 97%

Quality of life, anxiety, and depression in Turkish colorectal cancer patients

Alacacıoğlu

Binicier

Güngör

et al. 2009

Support Care Cancer

View full text Add to dashboard Cite

show abstract

“…From the time of diagnosis, the cancer patients experience different types of mental distress and adaptation to the process of cancer treatment including investigation, waiting for results, planning for surgery, chemotherapy, hormonal therapy, radiotherapy and recovery [23,24]. Interestingly, the result of a study by Kristin et al in postsurgery breast cancer patients showed that QoL improved over the first 6 months.…”

Section: Introductionmentioning

confidence: 99%

Anxiety, depression, perceived social support and quality of life in Malaysian breast cancer patients: A 1-year prospective study

Mohamed

See

et al. 2016

Eur. psychiatr.

View full text Add to dashboard Cite

Background: Depression and anxiety are common psychiatric morbidity among breast cancer patient. There is a lack of study examining the correlation between depression, anxiety and quality of life (QoL) with perceived social support (PSS) among breast cancer patients. This study aims to study the level of depression, anxiety, QoL and PSS among Malaysian breast cancer women over a period of 12 months and their associations at baseline, 6 and 12 months. Methods: It is a 12 months prospective cohort study. Two hundred and twenty one female patients were included in the study. They were assessed at the time of diagnosis, 6 months and 12 month using Hospital Anxiety and Depression Scale (HADS), Quality-of-Life Questionnaire (QLQ-C30), Version 3.0 of the EORTC Study Group and Multidimensional Scale of Perceived Social Support (MSPSS). The information of age, ethnicity, types of treatment, and staging of cancer were collected. Results: The HADS anxiety and depression subscales scores of the subjects were relatively low. The level of anxiety reduced significantly at 6 and 12 months (Baseline -6 months, p = 0.002; Baseline -12 months, p < 0.001). There were no changes in the level of depression over the study period. The global status of QoL and MSPSS scores were relatively high. Correlation between the global status of QoL and MSPSS for the study subjects was positive (Spearman's rho = 0.31-0.36). Global status of QoL and MSPSS scores were negatively correlated with anxiety and depression. Conclusion: Malaysian breast cancer women had relatively better QoL with lower level of anxiety and depression. Perceived social support was an important factor for better QoL and low level of psychological distress. It reflects the importance of attention on activities that enhance and maintain the social support system for breast cancer patients.

show abstract

“…The Distress Inventory for Cancer (DIC) since its first publication [32] has been substantially revised [33][34][35][36]. The data from a large sample of patients that had responded to the DIC version 2 were the basis, on which the present study is reported.…”

mentioning

confidence: 99%